Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention.

Tan N, Liu Y, Chen JY, Zhou YL, Li X, Li LW, Yu DQ, Chen ZJ, Liu XQ, Huang SJ.

Am Heart J. 2013 Apr;165(4):600-8. doi: 10.1016/j.ahj.2012.12.017. Epub 2013 Feb 14.

PMID:
23537978
3.

Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.

Tan N, Liu Y, Zhou YL, He PC, Yang JQ, Luo JF, Chen JY.

Catheter Cardiovasc Interv. 2012 Jan 1;79(1):70-5. doi: 10.1002/ccd.23048. Epub 2011 Oct 11. Erratum in: Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1256-7.

PMID:
21990069
4.

Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.

Liu Y, Liu YH, Chen JY, Tan N, Zhou YL, Duan CY, Yu DQ, Xie NJ, Li HL, Chen PY.

Medicine (Baltimore). 2015 Mar;94(12):e615. doi: 10.1097/MD.0000000000000615.

5.

Contrast Volume-to-Creatinine Clearance Ratio Predicts the Risk of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Reduced Ejection Fraction.

Liu Y, Chen SQ, Duan CY, Tan N, Chen JY, Zhou YL, Chen PY, Huang SJ, Liu XQ.

Angiology. 2015 Aug;66(7):625-30. doi: 10.1177/0003319714548442. Epub 2014 Aug 26.

PMID:
25158831
6.

Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.

Capodanno D, Ministeri M, Cumbo S, Dalessandro V, Tamburino C.

Catheter Cardiovasc Interv. 2014 May 1;83(6):907-12. doi: 10.1002/ccd.25153. Epub 2013 Aug 31.

PMID:
23934631
7.

Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.

Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR Jr; NHLBI Dynamic Registry Investigators.

J Am Coll Cardiol. 2007 Aug 14;50(7):584-90. Epub 2007 Jul 30.

8.

Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.

Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, He YT, Liu YH, Luo JF, Huang WH, Li G, He PC, Yang JQ, Xie NJ, Liu XQ, Yang DH, Huang SJ, Piao-Ye, Li HL, Ran P, Duan CY, Chen PY.

Circ Cardiovasc Interv. 2015 Jun;8(6). pii: e001859. doi: 10.1161/CIRCINTERVENTIONS.114.001859.

9.

Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL.

Ann Intern Med. 2009 Feb 3;150(3):170-7.

PMID:
19189906
10.

Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.

Nyman U, Björk J, Aspelin P, Marenzi G.

Acta Radiol. 2008 Jul;49(6):658-67. doi: 10.1080/02841850802050762.

PMID:
18568558
12.

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL.

J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5.

13.

The evaluation of creatinine clearance, estimated glomerular filtration rate and serum creatinine in predicting contrast-induced acute kidney injury among patients undergoing percutaneous coronary intervention.

Robert AM, Brown JR, Sidhu MS, Ramanath VS, Devries JT, Jayne JE, Hettleman BD, Friedman BJ, Niles NW 2nd, Kaplan AV, Malenka DJ, Robb JF, Thompson CA; Dartmouth Dynamic Registry Investigators.

Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):3-10. doi: 10.1016/j.carrev.2011.05.006. Epub 2011 Nov 16.

PMID:
22093591
14.

Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.

Nyman U, Almén T, Aspelin P, Hellström M, Kristiansson M, Sterner G.

Acta Radiol. 2005 Dec;46(8):830-42.

PMID:
16392608
15.

Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.

Wang YB, Fu XH, Gu XS, Wang XC, Zhao YJ, Hao GZ, Jiang YF, Fan WZ, Wu WL, Li SQ, Xue L.

Chin Med J (Engl). 2012 Mar;125(6):1063-7.

PMID:
22613532
16.

Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.

Wang XC, Fu XH, Wang YB, Jia XW, Wu WL, Gu XS, Zhang J, Su JL, Hao GZ, Jiang YF, Fan WZ, Li SQ.

Chin Med J (Engl). 2011 Mar;124(6):892-6.

PMID:
21518598
17.

Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.

Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD.

Nephrology (Carlton). 2010 Mar;15(2):165-70. doi: 10.1111/j.1440-1797.2009.01204.x.

PMID:
20470274
18.

Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.

Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW.

Am J Cardiol. 2004 Jun 15;93(12):1515-9.

PMID:
15194023
19.

Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.

Kardiol Pol. 2007 Jun;65(6):635-43; discussion 644.

20.

A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.

Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, Boura J, Aboufares A, Sporn D, Stapleton D.

Am J Cardiol. 2008 Mar 15;101(6):812-9. doi: 10.1016/j.amjcard.2007.10.051. Epub 2008 Jan 14.

PMID:
18328846

Supplemental Content

Support Center